De novo donor specific antibodies during acute rejection: An independent predictor of graft loss

被引:0
|
作者
Everly, M. [1 ]
Everly, J. [1 ]
Brailey, P. [1 ]
Susskind, B. [1 ]
Alloway, R. R. [1 ]
Woodle, E. S. [1 ]
机构
[1] Univ Cincinnati, Cincinnati, OH 45221 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
下载
收藏
页码:273 / 273
页数:1
相关论文
共 50 条
  • [41] De Novo HLA-DQ Donor Specific Antibodies Are Associated with a Higher Risk of Rejection and Transplant Glomerulopathy
    Willicombe, M.
    Santos-Nunez, E.
    Brookes, P.
    Roufosse, C.
    Cook, H. T.
    Galliford, J.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 203 - 203
  • [42] De Novo Donor Specific Antibodies Are Associated with Antibody Mediated Rejection in Patients Receiving Alemtuzumab Induction.
    Willicombe, Michelle
    Brookes, Paul
    Galliford, Jack
    McLean, Adam
    Warrens, Anthony
    Cairns, Tom
    Taube, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 234 - 235
  • [43] De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes
    Brooks, A. M. S.
    Carter, V.
    Liew, A.
    Marshall, H.
    Aldibbiat, A.
    Sheerin, N. S.
    Manas, D. M.
    White, S. A.
    Shaw, J. A. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (12) : 3239 - 3246
  • [44] MACHINE LEARNING PREDICTION FOR DE NOVO DONOR SPECIFIC ANTIBODIES (DNDSA), AMR AND GRAFT LOSS IN SIMULTANEOUS KIDNEY PANCREAS (SPK) TRANSPLANT RECIPIENTS
    Sharma, A.
    Coorey, C.
    Taverniti, A.
    Nankivell, B.
    Chapman, J.
    Craig, J.
    O'Connell, P.
    Pleass, H.
    Lim, W.
    Yang, J.
    Wong, G.
    NEPHROLOGY, 2018, 23 : 13 - 14
  • [45] Kidney transplant from HCV viremic donors to HCV-negative recipients and risk for de novo donor specific antibodies and acute rejection
    Daloul, Reem
    Sureshkumar, Kalathil
    Schnelle, Kendra
    Von Stein, Lauren
    Logan, April
    Pesavento, Todd
    CLINICAL TRANSPLANTATION, 2023, 37 (02)
  • [46] Failure to Remove De Novo Donor-Specific HLA Antibodies is Influenced by Antibody Properties and Identifies Kidney Recipients with Late Antibody-Mediated Rejection Destined to Graft Loss.
    Nocera, A.
    Cioni, M.
    Tagliamacco, A.
    Basso, S.
    Innocente, A.
    Fontana, I.
    Magnasco, A.
    Trivelli, A.
    Gurrado, A.
    Ramondetta, M.
    Boghen, S.
    Catenacci, L.
    Verrina, E.
    Garibotto, G.
    Ghiggeri, G.
    Cardillo, M.
    Ginevri, F.
    Comoli, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 777 - 777
  • [47] De Novo Donor Specific Antibodies and Late Graft Dysfunction: Another Reason to Treat Before the Damage is Done?
    Marco, I.
    Azor, J. Lopez
    Cosio, M. Garcia
    Mancebo, E.
    Chaverri, A. Rodriguez
    Caravaca, P.
    De Juan, J.
    Moran, L.
    Nuche, J.
    Jimenez, J. Delgado
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S168 - S168
  • [48] De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients
    Kaneku, H.
    O'Leary, J. G.
    Banuelos, N.
    Jennings, L. W.
    Susskind, B. M.
    Klintmalm, G. B.
    Terasaki, P. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (06) : 1541 - 1548
  • [49] De Novo Donor Specific Antibody (DSA) Is Associated with Decreased Kidney Graft Survival and Subclinical Antibody Mediated Rejection
    Nickerson, P.
    Blydt-Hansen, T.
    Rush, D.
    Birk, P.
    Ho, J.
    Karpinski, M.
    Storsley, L.
    Goldberg, A.
    Gibson, I. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 124 - 124
  • [50] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15